Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) indberetter hermed følgende transaktioner: 1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til dennea)NavnSøren Daniel...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions: 1.Details of the person discharging managerial responsibility / person closely associateda)NameSøren Daniel...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) indberetter hermed følgende transaktioner: 1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til dennea)NavnSøren Daniel...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions: 1.Details of the person discharging managerial responsibility / person closely associateda)NameSøren Daniel...
-
Bemærk venligst, at kvartalsrapporten kun foreligger på engelsk. Better than expected performance continued in Q3 (unaudited) Financial results in Q3 were again better than expected and the...
-
Better than expected performance continued in Q3 (unaudited) Financial results in Q3 were again better than expected and the full-year outlook has been updated accordingly. Execution of ALK’s growth...
-
Correction: The UK dial-in number was incorrect. Please find correct number below. On Friday, 9 November 2018, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its interim report for the six...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør delårsrapport for første ni måneder (Q3) 2018 fredag den 9. november 2018. ALK afholder samme dag kl. 13.30 (CET) en telefonkonference for...
-
On Friday, 9 November 2018, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its interim report for the six months ended 30 September 2018. ALK will host a meeting for analysts and institutional...
-
A shortage of adrenaline auto-injector pens continues to affect allergy sufferers worldwideAdditional data from ALK allows UK authority to extend use of specific batches of Jext® already in...